Leap Therapeutics Inc (LPTX): ***Additional Mega DD***Wallstreet Analy...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Leap Therapeutics Inc (LPTX)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	2529
Posts	69950
Boards Moderated	1
Alias Born	07/30/2012

Re: J0shy post# 119

Wednesday, 03/13/2019 7:43:06 PM

Wednesday, March 13, 2019 7:43:06 PM

***Additional Mega DD***Wallstreet Analysts Price predictions: $12.50

WallStreet Journal Price Targets: High $18.00 Medium: $12.50 Low $8.00

Brokerage Firm Ratings: 1 Buy rating, 2 Outperform 0 Sell and 0 Hold ratings

Valence Helix and affiliates recently acquired an 10.99% stake last month

CEO bought 571,428 shares @ $1.75
CFO bought 571,428 shares @ $1.75
COO bought 571,428 shares @ $1.75
Partnerships w/ Merck, Roche, Pfizer, Eli Lilly (owns 18% of LPTX)

72% tumor reduction

$LPTX

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent LPTX News

Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 11:10:19 AM
Leap Therapeutics Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/12/2024 11:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 10:50:46 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:48:28 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/24/2024 04:15:19 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/23/2024 08:25:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:10:27 AM
Leap Therapeutics Reports First Quarter 2024 Financial Results • PR Newswire (US) • 05/13/2024 11:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 10:50:43 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 09:01:55 PM
Leap Therapeutics Announces $40 Million Private Placement • PR Newswire (US) • 04/11/2024 12:30:00 PM
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 03/18/2024 11:00:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 02:36:12 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 02:36:06 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 02:35:49 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 02:35:24 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 02:35:23 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 02:34:58 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 02:34:30 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 02:34:18 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 01:41:24 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 01:39:35 AM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/26/2024 10:21:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 10:28:43 PM

More LPTX News

InvestorsHub NewsWire

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM

Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow